PrimeRFP SCOUT · Federal Contract Recompete Brief

75N94018D00003Nichd:r&d: BEST pharmaceuticals for children — Duke University

Duke University holds $183.3M across 191 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. Set-aside status: NONE.

National Institutes Of Health Nichd

Awarding office

Duke University

Recipient

—

Estimated value

AN12

PSC

NONE

Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Duke University — $90

Contract facts

NONE

Contract number75N94018D00003

AgencyNational Institutes Of Health Nichd

Awarding officeNational Institutes Of Health Nichd

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentDuke University

UEITP7EK8DZV6N5

PSCAN12

Related solicitationNIHNICHDOPPTB20182

NICHD:R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT IDIQ is a federal NONE award for National Institutes Of Health Nichd held by Duke University. Estimated value —. Related solicitation NIHNICHDOPPTB20182.

NICHD:R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT IDIQ

Incumbent footprint

Public record

Duke University — $183.3M obligated across 191 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($183.3M) · all agencies

Department of Health and Human Services (HHS)$172.3M · 94%Department of Defense (DOD)$4.6M · 3%Department of the Interior (DOI)$3.9M · 2%Department of Veterans Affairs (VA)$1.4M · 1%

Open full company profile →

Related awards

Same incumbent

36C24E25C0008

RNA EXTRACTION AND SEQUENCING

$293K

Sep 17, 2026

75F40123C00138

QUANTIFYING PATIENT PRIORITIES FOR CLINICAL EVIDENCE ON THE IMPACT OF OSSEOINTEGRATED LIMB…

$749K

Sep 28, 2026

75F40123C00183

TO PERFORM A TARGETED REVIEW OF LITERATURE REGARDING QUALITY OF LIFE OF PATIENTS WITH OAB …

$749K

Sep 29, 2026

W912HQ25P0096

IWR - BAYESIAN ENHANCEMENT OF FLOOD RISK MANAGEMENT DEPTH-DAMAGE MODELING. INCORPORATE A H…

$206K

Sep 29, 2026

W81XWH22C0123

RESEARCH AND DEVELOPMENT TBI AND PSYCHOLOGICAL HEALTH RESEARCH PROGRAM PROPOSAL TP210599

$3.0M

Dec 28, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N94018D00003?

75N94018D00003 (Nichd:r&d: BEST pharmaceuticals for children) is a National Institutes Of Health Nichd award with an estimated value of —, currently held by Duke University. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N94018D00003?

National Institutes Of Health Nichd awarded 75N94018D00003 to Duke University.

Who is the incumbent on 75N94018D00003?

Duke University is the incumbent with $183.3M across 191 related awards in SCOUT’s public footprint.

When does Duke University’s 75N94018D00003 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N94018D00003 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthly